Article published Aug 14, 2026. Prices below use latest available snapshots.
Editorial Note: IQV at $179.17 RSI 52 — a modest pullback from May 29 ($182.21, RSI 61.8). -6.15% over 7D but +3.68% over 30D; price is now just +0.6% above SMA20 ($178.18), essentially at the moving average. RSI 52 is neutral — the constructive trend improvement from April/May is consolidating rather than reversing. HELD POSITION (9 shares @ $164.63 avg) remains in-the-money at approximately +8.8% unrealized at current price. -27.48% from 52wk high still leaves substantial recovery runway. The 7D pullback (-6.15%) is notable but RSI holding above 50 and price above SMA20 are both positive. The clinical trials data analytics thesis is unchanged. Watch for SMA20 to hold as support — a clean bounce here with RSI staying above 45 would confirm the recovery trend remains intact.
2026-07-11 tape note: No contradiction — the SMA20-hold scenario the 06-16 note asked to watch for played out and then some. IQV $207.85, RSI 68.3 (approaching but not yet overbought), now +9.6% above SMA20 and +6.1% above SMA200. 30D accelerated to +14.8%, 3M to +20.85%, and the gap to the 52wk high has closed sharply to -15.87% (from -27.48%). HELD POSITION now ~+26.3% unrealized (9 shares @ $164.63 avg vs $207.85). New watch item: RSI at 68.3 is close to overbought — a fresh cooling-off leg wouldn't be surprising after this run.
2026-07-17 tape note: The cooling-off flagged as a watch item has arrived, mildly. IQV $206.26, RSI 62.4 (down from 68.3), now +4.7% above SMA20 ($197.03) — still comfortably above but off the extended reading. 7D -0.76%, 30D +22.94% (still accelerating), 3M +16.69%. -16.51% from 52wk high, essentially flat. HELD POSITION (9 shares @ $164.63 avg) still deeply in the money at current price. No new fundamentals re-researched; this is a healthy RSI reset, not a reversal.
2026-07-25 tape note (Friday 2026-07-24 close): Still firm. IQV $208.05 (+0.9% vs $206.26), RSI 61.6 (essentially flat) — +2.0% above SMA20 (narrowed from +4.7%, price consolidating closer to the average), +10.9% above SMA50, +5.8% above SMA200. 7D has flipped positive to +0.87% (from -0.76%), 30D has moderated to +12.08% (from +22.94%), and 3M has accelerated further to +28.2% (from +16.69%). -16.08% from 52wk high, essentially flat vs -16.51%. HELD POSITION (9 shares @ $164.63 avg) remains deeply in the money at current price. No new fundamentals re-researched.
2026-07-28 tape note — SHARP SINGLE-DAY MOVE: IQV $242.94 (+16.8% vs $208.05), a +13.94% single-day jump, RSI 79.1 (up sharply from 61.6, now firmly overbought — the highest reading this file has tracked). +17.4% above SMA20 (widened from +2.0%), +28.5% above SMA50, +23.4% above SMA200. 7D has jumped to +20.49% (from +0.87%), 30D to +25.69% (from +12.08%), and 3M has accelerated sharply to +55.07% (from +28.2%). -1.93% from 52wk high — essentially at new highs, a sharp improvement from -16.08%. Regime now tagged "parabolic." HELD POSITION (9 shares @ $164.63 avg) is now well further in the money. No fundamentals re-researched this cycle — no company-specific news identified here for the size of this move; treat as a sharp overbought extension, not confirmation to add at these levels. Per the full-scan summaries (2026-07-28 close). 2026-07-31 tape note: IQV $235.02 (-3.26% vs $242.94), RSI 68.2 (cooled from 79.1). 7D +12.96% (decelerated from +20.49%), 30D +15.66% (decelerated from +25.69%), 3M +48.96% (decelerated from +55.07%). From the 52-week high, the gap is -6.50% (widened from -1.93%). Per the tape: trend "up", regime "uptrend", no golden cross. No new fundamentals re-researched. Per the full-scan summaries (2026-07-31 close). 2026-08-08 tape note: IQV $238.70 (+1.57% vs $235.02), RSI 65.5 (cooled from 68.2). 7D +1.57% (moderated from +12.96%), 30D +17.13% (accelerated from +15.66%), 3M +33.57% (moderated from +48.96%). From the 52-week high, the gap is -6.09% (narrowed from -6.50%). Per the tape: trend "strong-up", regime "uptrend", golden cross intact. No new fundamentals re-researched. Per the full-scan summaries (2026-08-07 close). 2026-08-14 tape note: IQV $236.66 (-0.85% vs $238.70), RSI 61.6 (cooled from 65.5). 7D -0.85% (turned negative from +1.57%), 30D +14.43% (moderated from +17.13%), 3M +39.94% (accelerated from +33.57%). From the 52-week high, the gap is -3.91% (narrowed from -6.09%). Per the tape: trend "strong-up", regime "uptrend", golden cross intact. No new fundamentals re-researched. Per the full-scan summaries (2026-08-14 close).
Price Data (2026-08-14 tape)
| Metric | Value |
|---|---|
| Price | $236.66 |
| RSI (14) | 61.6 |
| SMA20 | $226.64 (+4.4%) |
| SMA50 | $205.25 (+15.3%) |
| SMA200 | $198.57 (+19.2%) |
| Trend | strong-up |
| Golden cross | Yes |
| Regime | uptrend |
| 7D | -0.85% |
| 30D | +14.43% |
| 3M | +39.94% |
| From 52wk High | -3.91% |
Key Changes vs 2026-07-28
| Metric | 2026-07-28 | 2026-07-31 | Change |
|---|---|---|---|
| Price | $242.94 | $235.02 | down |
| RSI | 79.1 | 68.2 | cooled |
| vs SMA20 | +17.4% | +10.1% | narrowed |
| 30D | +25.69% | +15.66% | decelerated |
| 3M | +55.07% | +48.96% | decelerated |
| 52wk High | -1.93% | -6.50% | widened |
Research Log
| Date | Note |
|---|---|
| 2026-04-10 | Initial deep dive. IQV $165.65, RSI 41.6, strong-down. Death cross. Held 9 shares @ $164.63 avg, +0.6% P/L. |
| 2026-05-29 | IQV $182.21, RSI 61.8, weak-up; +15.05% 30D. Trend reversing; held position now ~+10.7% unrealized. No new fundamentals re-researched. |
| 2026-06-16 | IQV $179.17, RSI 52, neutral; -6.15% 7D, +3.68% 30D. 7D pullback from May 29; price back at SMA20. Held position ~+8.8% unrealized. Recovery trend intact but consolidating. SMA20 hold is the key tell. No new fundamentals re-researched. |
| 2026-07-11 | IQV $207.85, RSI 68.3, up; +16.0% since 06-16. SMA20-hold scenario confirmed and accelerated — 30D +14.8%, 3M +20.85%, held position ~+26.3% unrealized. RSI approaching overbought — new watch item. No new fundamentals re-researched. |
| 2026-07-17 | IQV $206.26, RSI 62.4, up; -0.8% since 07/11, +22.94% 30D (still accelerating), +16.69% 3M. RSI cooled off the near-overbought read, a healthy reset rather than a reversal — held position still deeply in the money. No new fundamentals re-researched. |
| 2026-07-25 | IQV $208.05, RSI 61.6, up; +0.9% since 07/17, +12.08% 30D (moderated), +28.2% 3M (accelerated). Consolidating above all major MAs; held position still deeply in the money. No new fundamentals re-researched. |
| 2026-07-28 | IQV $242.94, RSI 79.1, up (regime: parabolic); +16.8% since 07/25 (+13.94% single day), +25.69% 30D, +55.07% 3M. -1.93% from 52wk high, near new highs. RSI now overbought. no news identified Correction 2026-08-03: the +13.94% day was IQV's July 28 earnings reaction (+16.1% across the print, per its calendar event) — not an unexplained extension. Held position well further in the money. No new fundamentals re-researched. |
| 2026-07-31 | IQV $235.02, RSI 68.2, up; 7D +12.96%; 30D +15.66%; 3M +48.96%; -6.50% from 52wk high. No new fundamentals re-researched. |
| 2026-08-08 | IQV $238.70, RSI 65.5, strong-up; 7D +1.57%; 30D +17.13%; 3M +33.57%; -6.09% from 52wk high. No new fundamentals re-researched. |
| 2026-08-14 | IQV $236.66, RSI 61.6, strong-up; 7D -0.85%; 30D +14.43%; 3M +39.94%; -3.91% from 52wk high. No new fundamentals re-researched. |
Sources
- Tape data (price/RSI/SMA/returns): full-scan pre-computed summaries as of the 2026-07-31 tape — biotech-capital-cycle.
- Prior-cycle history: this file's dated update log (refreshed each full scan).